Augmented Care at Worksite for Diabetes Prevention
Impact of Augmented Care at the Worksite for Diabetes Prevention
1 other identifier
interventional
208
1 country
1
Brief Summary
The purpose of the study was to evaluate the impact of augmented care at the worksite through a lifestyle intervention for diabetes prevention among employees with prediabetes who were slower to respond to a standard diabetes prevention intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2017
CompletedFirst Posted
Study publicly available on registry
December 26, 2017
CompletedStudy Start
First participant enrolled
February 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2022
CompletedResults Posted
Study results publicly available
April 11, 2024
CompletedApril 11, 2024
March 1, 2024
4.2 years
December 19, 2017
February 9, 2024
March 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Percent Weight Change
Change in weight as measured in light clothing and shoes removed
baseline and 4-months
Percent Weight Change
Change in weight as measured in light clothing and shoes removed
baseline and 12-months
Percent Weight Change
Change in weight as measured in light clothing and shoes removed
12-months and 18-months
Secondary Outcomes (3)
Fasting Glucose
baseline and 4-months
Fasting Glucose
baseline and 12-months
Fasting Glucose
12-months and 18-months
Study Arms (2)
Group Lifestyle Balance (GLB)
ACTIVE COMPARATORStandard lifestyle intervention to promote weight loss
Group Lifestyle Balance Plus (GLB+)
EXPERIMENTALAugmented lifestyle intervention for early slow responders
Interventions
The intervention included the following key features: group-based sessions led by a lifestyle coach; a structured, state-of-the-art, 16-session core-curriculum that emphasized behavioral self-management strategies for weight loss and physical activity; 8-months of extended care with bimonthly or monthly sessions; self-monitoring of diet and physical activity.
The GLB+ intervention arm included participants who did not achieve the targeted percent weight loss by week 5 and incorporated enhanced training in values clarification, mindful decision making, planning, and problem solving. GLB+ included the same number of group-based sessions as GLB.
Eligibility Criteria
You may qualify if:
- Benefits-eligible Ohio State University (OSU) employee
- Intend to be employed by OSU through the length of the follow-up phase
- Body mass index: \>24 kg/m\^2 non-Asians; \>22 kg/m\^2 Asians
- Fasting blood glucose of 100-125 mg/dL or an A1c of 5.7-6.4%
- Blood glucose of 110-199 (if non-fasting in previous 2 hours)
You may not qualify if:
- Blood glucose level of ≥ 200 mg/dL
- Conditions that would limit adoption of light/moderate physical activity (i.e., cardiac event, severe chronic obstructive pulmonary disease, advanced arthritis, poorly controlled hypertension)
- Chronic use of medications that affect blood glucose levels (i.e., corticosteroids)
- Concurrent participation in a structured weight loss program or counseling for bariatric surgery
- Pregnant or breastfeeding
- Score of ≥ 10 on the Patient Health Questionnaire-8 indicating moderate to severe depressive symptoms
- Score of ≥ 27 on the Binge Eating Scale indicating the potential for binge eating
- Unwilling to accept randomization
- Planning to move from the area or changing employment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University
Columbus, Ohio, 43210, United States
Related Publications (3)
Miller CK, Nagaraja HN, Cheavens JS, Fujita K, Lazarus SA, Brunette DS. Sex Differences in Early Weight Loss Success During a Diabetes Prevention Intervention. Am J Health Behav. 2023 Apr 30;47(2):337-348. doi: 10.5993/AJHB.47.2.13.
PMID: 37226352DERIVEDMiller CK, King D, Nagaraja HN, Fujita K, Cheavens J, Focht BC. Impact of an augmented intervention on self-regulatory, dietary and physical activity outcomes in a diabetes prevention trial among adults with prediabetes. J Behav Med. 2023 Oct;46(5):770-780. doi: 10.1007/s10865-023-00406-w. Epub 2023 Mar 18.
PMID: 36933057DERIVEDMiller CK, Nagaraja HN, Cheavens J, Fujita K, Lazarus S. Impact of a Novel Diabetes Prevention Intervention for Early Slow Weight Loss Responders Among Adults With Prediabetes: An Adaptive Trial. Diabetes Care. 2022 Oct 1;45(10):2452-2455. doi: 10.2337/dc22-0824.
PMID: 36041053DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Four participant cohorts did not complete the 18-month visit due to pandemic-related restrictions during the SARS-CoV-2 pandemic. Thus, the 18-month outcomes include a smaller sample and should be interpreted with caution.
Results Point of Contact
- Title
- Dr. Carla Miller (current affiliation)
- Organization
- Indiana University
Study Officials
- PRINCIPAL INVESTIGATOR
Carla Miller, Ph.D.
The Ohio State University (during study implementation)
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor (current affiliation at Indiana University)
Study Record Dates
First Submitted
December 19, 2017
First Posted
December 26, 2017
Study Start
February 8, 2018
Primary Completion
April 15, 2022
Study Completion
April 15, 2022
Last Updated
April 11, 2024
Results First Posted
April 11, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- The data will be available following all analyses and publication of primary and secondary study results. The data will be available upon request.
- Access Criteria
- To be developed
De-identified data will be released to other researchers using a data-sharing agreement that specifies that the data will be used only for research purposes and only by the specified individuals to whom the data are released. Documentation of Institutional Review Board approval for the proposed use must be provided in advance to the PI. The data must be either destroyed or returned to the PI after all analyses are completed.